New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export MRK’s income statement to Excel — free account
Merck & Co., Inc.
MRKHealthcare Drug Manufacturers General
Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.
- Revenue
- +4.68%
- EPS
- −12.1%
- Free cash flow
- −19.3%
- Total debt
- +24.3%
Quarter to September 2026, against a year earlier
135.01
2.27
+1.71%
Follow MRK
Alert me
Revenue to profit Fiscal 2025, year to Dec 31, 2025
Of every $100 of revenue, $28.09 was left as profit. What is an income statement?
| Revenue | 65.0 | 100.0% |
|---|---|---|
| Cost of revenue | −16.4 | −25.2% |
| Gross profit | 48.6 | 74.8% |
| Research & development | −15.8 | −24.3% |
| Selling, general & admin | −10.7 | −16.5% |
| Operating income | 22.1 | 34.0% |
| Other income, net | −1.0 | −1.6% |
| Income tax | −2.8 | −4.3% |
| Net income | 18.3 | 28.1% |
Net margin (right axis)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.8B | $40.1B | $42.3B | $39.1B | $41.5B | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |
| Operating income | $5.5B | $6.8B | $8.9B | $7.9B | $5.5B | $13.2B | $18.3B | $3.0B | $20.2B | $22.1B |
| Net income | $3.9B | $2.4B | $6.2B | $5.6B | $4.5B | $12.4B | $14.5B | $377M | $17.1B | $18.3B |
| Net margin (right axis) | 9.9% | 6.0% | 14.6% | 14.3% | 10.9% | 25.4% | 24.5% | 0.6% | 26.7% | 28.1% |
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
39,807.00 | 40,122.00 | 42,294.00 | 39,121.00 | 41,518.00 | 48,704.00 | 59,283.00 | 60,115.00 | 64,168.00 | 65,011.00 |
Revenue Growth |
0.78% | 0.79% | 5.41% | (7.50%) | 6.13% | 17.31% | 21.72% | 1.40% | 6.74% | 1.31% |
Cost of Revenue |
14,030.00 | 12,912.00 | 13,509.00 | 12,016.00 | 13,618.00 | 13,626.00 | 17,411.00 | 16,126.00 | 15,193.00 | 16,382.00 |
Gross Profit |
25,777.00 | 27,210.00 | 28,785.00 | 27,105.00 | 27,900.00 | 35,078.00 | 41,872.00 | 43,989.00 | 48,975.00 | 48,629.00 |
R&D Expenses |
10,261.00 | 10,339.00 | 9,752.00 | 9,724.00 | 13,397.00 | 12,245.00 | 13,548.00 | 30,531.00 | 17,938.00 | 15,789.00 |
SG&A Expenses |
10,017.00 | 10,074.00 | 10,102.00 | 9,455.00 | 8,955.00 | 9,634.00 | 10,042.00 | 10,504.00 | 10,816.00 | 10,733.00 |
Operating Income |
5,499.00 | 6,797.00 | 8,931.00 | 7,926.00 | 5,548.00 | 13,199.00 | 18,282.00 | 2,954.00 | 20,221.00 | 22,107.00 |
Non-operating Income/Expense |
(840.00) | (276.00) | (230.00) | (755.00) | 315.00 | 680.00 | (1,838.00) | (1,065.00) | (285.00) | (1,040.00) |
| 4,659.00 | 6,521.00 | 8,701.00 | 7,171.00 | 5,863.00 | 13,879.00 | 16,444.00 | 1,889.00 | 19,936.00 | 21,067.00 | |
Income Tax Provision |
718.00 | 4,103.00 | 2,508.00 | 1,565.00 | 1,340.00 | 1,521.00 | 1,918.00 | 1,512.00 | 2,803.00 | 2,804.00 |
Income after Tax |
3,941.00 | 2,418.00 | 6,193.00 | 5,606.00 | 4,523.00 | 12,358.00 | 14,526.00 | 377.00 | 17,133.00 | 18,263.00 |
Non-Controlling Interest |
21.00 | 24.00 | (27.00) | (84.00) | 4.00 | 13.00 | 7.00 | 12.00 | 16.00 | 9.00 |
Net Income Common |
3,920.00 | 2,394.00 | 6,220.00 | 9,843.00 | 7,067.00 | 13,049.00 | 14,519.00 | 365.00 | 17,117.00 | 18,254.00 |
EPS (Basic) |
1.42 | 0.93 | 2.32 | 3.81 | 2.78 | 5.16 | 5.73 | 0.14 | 6.74 | 7.28 |
EPS (Diluted) |
1.41 | 0.93 | 2.32 | 3.81 | 2.78 | 5.14 | 5.71 | 0.14 | 6.74 | 7.28 |
Shares (Basic, Weighted) |
2,766.00 | 2,730.00 | 2,664.00 | 2,565.00 | 2,530.00 | 2,530.00 | 2,532.00 | 2,537.00 | 2,532.00 | 2,502.00 |
Shares (Diluted, Weighted) |
2,787.00 | 2,748.00 | 2,679.00 | 2,580.00 | 2,541.00 | 2,538.00 | 2,542.00 | 2,547.00 | 2,541.00 | 2,507.00 |
Gross Margin |
64.75% | 67.82% | 68.06% | 69.29% | 67.20% | 72.02% | 70.63% | 73.17% | 76.32% | 74.80% |
EBIT Margin |
13.81% | 16.94% | 21.12% | 20.26% | 13.36% | 27.10% | 30.84% | 4.91% | 31.51% | 34.01% |
EBT margin |
11.70% | 16.25% | 20.57% | 18.33% | 14.12% | 28.50% | 27.74% | 3.14% | 31.07% | 32.41% |
Net Profit Margin |
9.85% | 5.97% | 14.71% | 25.16% | 17.02% | 26.79% | 24.49% | 0.61% | 26.68% | 28.08% |
Free Cash Flow Margin |
22.01% | 11.37% | 19.64% | 14.10% | 7.68% | 17.81% | 24.81% | 15.21% | 28.20% | 19.01% |
EBITDA |
10,970.00 | 11,473.00 | 13,450.00 | 11,236.00 | 9,034.00 | 16,413.00 | 22,191.00 | 6,826.00 | 24,720.00 | 27,945.00 |
EBIT |
5,499.00 | 6,797.00 | 8,931.00 | 7,926.00 | 5,548.00 | 13,199.00 | 18,282.00 | 2,954.00 | 20,221.00 | 22,107.00 |
Income from Continuous Operations |
3,941.00 | 2,418.00 | 6,193.00 | 5,606.00 | 4,523.00 | 12,358.00 | 14,526.00 | 377.00 | 17,133.00 | 18,263.00 |
Income from Discontinued Operations |
— | — | — | 4,153.00 | 2,548.00 | 704.00 | — | — | — | — |
Consolidated Net Income/Loss |
3,941.00 | 2,418.00 | 6,193.00 | 9,759.00 | 7,071.00 | 13,062.00 | 14,526.00 | 377.00 | 17,133.00 | 18,263.00 |
EPS (Basic, from Continuous Ops) |
1.42 | 0.89 | 2.32 | 2.22 | 1.79 | 4.88 | 5.74 | 0.15 | 6.77 | 7.30 |
EPS (Basic, from Discontinued Ops) |
— | — | — | 1.62 | 1.01 | 0.28 | — | — | — | — |
EPS (Basic, Consolidated) |
1.42 | 0.89 | 2.32 | 3.80 | 2.79 | 5.16 | 5.74 | 0.15 | 6.77 | 7.30 |
EPS (Diluted, from Cont. Ops) |
1.41 | 0.88 | 2.31 | 2.21 | 1.78 | 4.86 | 5.71 | 0.15 | 6.74 | 7.28 |
EPS (Diluted, from Disc. Ops) |
— | — | — | 0.00 | 0.00 | 0.00 | — | — | — | — |
Shares (Diluted, Average) |
2,787.00 | 2,748.00 | 2,679.00 | 2,580.00 | 2,541.00 | 2,538.00 | 2,542.00 | 2,547.00 | 2,541.00 | 2,507.00 |
EPS (Diluted, Consolidated) |
1.41 | 0.88 | 2.31 | 3.78 | 2.78 | 5.15 | 5.71 | 0.15 | 6.74 | 7.28 |
EBITDA Margin |
27.56% | 28.60% | 31.80% | 28.72% | 21.76% | 33.70% | 37.43% | 11.35% | 38.52% | 42.99% |
Operating Cash Flow Margin |
26.07% | 16.08% | 25.82% | 22.71% | 18.35% | 26.94% | 32.21% | 21.64% | 33.46% | 25.34% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026